ARCA biopharma ABIO
$ 28.8
1052.0%
Quarterly report 2024-Q3
added 11-13-2024
ARCA biopharma Cash Flow 2011-2024 | ABIO
Annual Cash Flow ARCA biopharma
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-5.01 M | -10.9 M | -18.8 M | -7.72 M | -4.8 M | -8.24 M | -17.5 M | - | - | - | -5.29 M | -4.08 M | -6.96 M |
Depreciation & Amortization |
15 K | 20 K | 16 K | 8 K | 18 K | 22 K | 27 K | 24 K | 19 K | 12 K | 26 K | 43 K | 602 K |
Accounts Payables |
362 K | 334 K | 1.12 M | 1.77 M | 418 K | 230 K | 622 K | 1.2 M | 364 K | 795 K | 597 K | 65 K | 260 K |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow ARCA biopharma
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -1.53 M | - | - | - | -1.6 M | - | -9.42 M | - | -4.3 M | - | -13.8 M | - | -5.22 M | - | -4.73 M | -2.73 M | -1.69 M | - | -3.64 M | -2.76 M | -1.57 M | - | -6.9 M | -5.32 M | -3.07 M | - | -13.3 M | -9.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -764 K | - | -3.41 M | -2.63 M | -1.66 M | - | -5.72 M | -4.05 M | -1.94 M |
Depreciation & Amortization |
- | - | 3 K | - | - | - | 4 K | - | 15 K | - | 5 K | - | 11 K | - | 3 K | - | 6 K | 4 K | 3 K | - | 16 K | 11 K | 5 K | - | 17 K | 11 K | 6 K | - | 21 K | 14 K | 7 K | - | 17 K | 9 K | 5 K | - | 14 K | 9 K | 4 K | - | 8 K | 5 K | 3 K | - | 24 K | 19 K | 10 K | - | 34 K | 24 K | 14 K | - | 518 K | 195 M | 81 K |
Accounts Payables |
2.14 M | 571 K | 529 K | 362 K | 322 K | 241 K | 366 K | 334 K | 593 K | - | 1.01 M | 1.12 M | 1.13 M | 2.18 M | 1.58 M | 1.77 M | 1.77 M | 1.77 M | 1.77 M | 418 K | 418 K | 418 K | 418 K | 230 K | 230 K | 230 K | 230 K | 622 K | 622 K | 622 K | 622 K | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 364 K | 364 K | 364 K | 364 K | 795 K | 795 K | 795 K | 795 K | 597 K | 597 K | 597 K | 597 K | 65 K | 65 K | 65 K | 65 K | 260 K | 260 K | 260 K | 260 K |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency